Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Castleman Disease × siltuximab × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Multiple Myeloma 10 Neoplasms, Plasma Cell 3 Cytokine Release Syndrome 3 Lymphoma, Non-Hodgkin 2 Smoldering Multiple Myeloma 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Monoclonal Gammopathy of Undetermined Significance 1 Lymphoma 1 Immunoglobulin Light-chain Amyloidosis 1 Castleman Disease 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00412321 2014-07-01

A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease

Centocor, Inc.

Phase 1 Completed

LymphoidPlasma cell

Castleman Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡